Description
Research Applications:
Melanocortin Receptor Signaling
PT-141, also known as bremelanotide, is a melanocortin receptor agonist used in research contexts to study receptor activation, selectivity, and downstream neuroendocrine signaling [1].
Its cyclic peptide structure makes it useful in comparative assays of melanocortin analog design and receptor-family pharmacology.
Neuroendocrine Research Models
Research models may evaluate PT-141 alongside other melanocortin peptides to assess pathway-specific cellular outputs, second messenger activity, and receptor bias.
Peptide Design and SAR Context
The compound is appropriate for non-clinical structure-activity comparisons within melanocortin peptide libraries. No therapeutic use is implied.
Referenced Citations:
- Bremelanotide compound reference
Source: PubChem compound reference for PT-141 / bremelanotide.
Reviews
There are no reviews yet.